Cilmostim

Drug Profile

Cilmostim

Alternative Names: CSF-1; M-CSF; Macrophage colony-stimulating factor - Genetics Institute; Macstim; Recombinant human macrophage colony stimulating factor; rhM-CSF

Latest Information Update: 14 Aug 1996

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Wyeth
  • Developer Schering-Plough; Wyeth
  • Class Macrophage colony stimulating factors
  • Mechanism of Action Macrophage colony stimulating factor stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Cancer; Hypercholesterolaemia

Most Recent Events

  • 14 Aug 1996 Discontinued-II for Hypercholesterolaemia in USA (Unknown route)
  • 07 Aug 1996 Discontinued-II for Cancer in USA (IV)
  • 07 Aug 1996 Phase-II clinical trials for Hypercholesterolaemia in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top